Cargando…
Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
In recent years, multiple studies including ours have reported on the mechanism of resistance towards valosin-containing protein (VCP) inhibitors. While all these studies reported target alterations via mutations in VCP as the primary mechanism of resistance, discrepancies persist to date regarding...
Autores principales: | Bastola, Prabhakar, Bilkis, Rabeya, De Souza, Cristabelle, Minn, Kay, Chien, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662852/ https://www.ncbi.nlm.nih.gov/pubmed/31358864 http://dx.doi.org/10.1038/s41598-019-47085-9 |
Ejemplares similares
-
Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2018) -
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
por: Ju, Jeong-Sun, et al.
Publicado: (2009) -
Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
por: Ferrari, Veronica, et al.
Publicado: (2022) -
Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants
por: Zhang, Ting, et al.
Publicado: (2017) -
Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2017)